HIV-1 infection induces differentiation of immature neural cells through autocrine tumor necrosis factor and nitric oxide production

Virology

Volumn 261, Issue 2, 1999, Pages 193-204

  Obregón, Eva ^a   Punzón, Carmen ^a   Fernández Cruz, Eduardo ^a   Fresno, Manuel ^a   Muñoz Fernández, M Angeles ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MESSENGER RNA; NERVE GROWTH FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; GENE ACTIVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033200264     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9848     Document Type: Article

References (63)

1. Adamson D. C., Wildemann B., Sasaki M., Glass J. D., McArthur J. C., Christov V. I., Dawson T. M., Dawson V. L. Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41. Science. 274:1996;1917-1921.
2. Alcami J., Lain de Lera T., Folgueira L., Pedraza M. A., Jacque J.-M., Bachelerie F., Noriega A. R., Hay R. T., Harrich D., Gaynor R. B., Virelizier J.-L., Arenzana-Seisdedos F. Absolute dependence on κB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J. 14:1995;1552-1560.
3. An S. F., Scaravilli F. Early HIV-1 infection of the central nervous system. Arch. Anat. Cytol. Pathol. 45:1997;94-105.
4. Aoki-Sei S., Yarchoan R., Kageyama S., Hoekzema D. T., Pluda J. M., Wyvill K. M., Broder S., Mitsuya H. Plasma HIV-1 viremia in HIV-1 infected individuals assessed bypolymerase chain reaction. AIDS Res. Hum. Retroviruses. 8:1992;1263-1270.
5. Baeuerle P. A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
6. Belman A. L. HIV-1-associated CNS disease in infants and children. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 72:1994;289-310.
7. Biedler J. L., Spengler B. A., Chang T. D., Ross R. A. Differential expression of intermediate filaments and fibronectin in human NBs. Adv. Neuroblastoma Res. 2:1988;277-289.
8. Bredt D. S., Snyder S. H. Nitric oxide: A physiologic messenger molecule. Annu. Rev. Biochem. 63:1994;175-195.
9. Brew B., Rosenblum M., Cronin K., Price R. The AIDS dementia complex and HIV-1 brain infection: Clinical-virological correlations. Ann. Neurol. 38:1995;563-570.
10. Budka H. Human immunodeficiency virus (HIV)-induced disease of the central nervous system: Pathology and implications for pathogenesis. Acta Neuropathol. 77:1989;225-236.
11. Bukrinsky M. I., Nottet H. S., Schmidtmayerova H., Dubrovsky L., Flanagan C. R., Mullins M. E., Lipton S. A., Genderman H. E. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease. J. Exp. Med. 181:1995;735-745.
12. Buzy J. M., Lindstrom L. M., Zink M. C., Clements J. E. HIV-1 in the developing CNS: developmental differences in gene expression. Virology. 210:1995;361-371.
13. Chen P., Mayne M., Power C., Nath A. The Tat protein of HIV-1 induces tumor necrosis factor-α production. J. Biol. Chem. 272:1997;22385-22388.
14. Cinque P. L., Vago Ceresa D., Mainini F., Terreni M. R., Vagani A., Torri W., Bossolasco S., Lazzarin A. Cerebrospinal fluid HIV-1 RNA levels: Correlation with HIV encephalitis. AIDS. 12:1998;389-394.
15. Dubois-Dalcq M., Altmeyer R., Chiron M., Wilt S. HIV interactions with cells of the immune system. Curr. Opin. Neurobiol. 5:1995;647-655.
16. Ensoli F., Cafaro A., Fiorelli V., Vannelli B., Ensoli B., Thiele C. J. HIV-1 infection of primary human neuroblasts. Virology. 210:1995;221-225.
17. Ensoli F., Ensoli B., Thiele C. J. HIV-1 gene expression and replication in neuronal and glial cell lines with immature phenotype: effects of nerve growth factor. Virology. 200:1994;668-676.
18. Epstein L. G., Sharer L. R., Joshi V. V., Fojas M. M., Koenigsberger M. R., Oleske M. Progressive encephalopathy in children with acquired immunodeficiency syndrome. Ann. Neurol. 17:1985;488-496.
19. Fauci A. S. Host factors and the pathogenesis of HIV-induced disease: Implications for therapy. Science. 384:1996;529-534.
20. Gelbard H. A., Nottet H. S., Swindells S., Jett M., Dzenko K. A., Genis P., White R., Wang L., Choi Y. B., Zhang D., Lipton S. A., Tourtellotte W. W., Epstein L. G., Gendelman H. E. Platelet-activating factor: A candidate human immunodeficiency virus type 1-induced neurotoxin. J. Virol. 68:1994;4628-4235.
21. Geller D. A., Nussler A. K., Di Silvio M. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl. Acad. Sci. USA. 90:1993;522-526.
22. Glass J. D., Johnson R. T. Human immunodeficiency virus and the brain. Annu. Rev. Neurosci. 19:1996;1-26.
23. Gross J., Favre B., Meyer M. Differentiation-related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants. Int. J. Cancer. 52:1992;85-91.
24. Harouse J. M., Kunsch C., Hartle H. T., Laughlin M. A., Hoxie J. A., Wigdahl B., Gonzalez-Scararano F. CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J. Virol. 63:1989;2527-2533.
25. Janssen R. S., Cornblath D. R., Epstein L. G., McArthur J., Price R. W. Human immunodeficiency virus (HIV) infection and the nervous system: Report from the American Academy of Neurology, AIDS task force. Neurology. 39:1989;119-122.
26. Kärber G. Beitragë zur kollektiven behandlung pharmalologischer reihenversuche. Arch. Exp. Pathol. Pharmakol. 162:1931;480-483.
27. Kifle Y., Monnier J., Chesrown S. E., Raizada M. K., Nick H. S. Regulation of the manganese superoxide dismutase and inducible nitric oxide synthase gene in rat neuronal and glial cells. J. Neurochem. 6:1996;2128-2135.
28. Knowles R. G., Moncada S. Nitric oxide synthases in mammals. Biochem. J. 298:1994;249-259.
29. Koenig S., Gendelmam H. E., Orenstein J. M., Canto M. C. D., Pezeshkpour G. H., Yungbluth M., Janotta F., Aksamit A., Martin M. A., Fauci A. S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 233:1986;1089-1093.
30. Köller H., Siebler M., Hartung H. P. Immunologically induced electrophysiological dysfunction: Implications for inflammatory diseases of the CNS and PNS. Prog. Neurobiol. 52:1997;1-26.
31. Kolson D. L., Lavi E., Gonzalez-Scarano F. The effects of human immunodeficiency virus in the central nervous system. Adv. Virus. Res. 50:1998;1-47.
32. Lander H. M., Sehajpal P., Levine D. M., Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150:1993;1509-1516.
33. Li X. L., Moudgil T., Vinters H. V., Ho D. D. CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1. J. Virol. 64:1990;1383-1387.
34. Liem R. K. H., Yen S. H., Salomon G. D., Shelanski M. L. Intermediate filaments in nervous tissues. J. Cell Biol. 79:1978;637-645.
35. Magnusson S., Almand P., Kanje M. Inducible nitric oxide synthase increases in regenerating rat ganglia. Neuroreport. 7:1996;2046-2050.
36. Masliah E., Ge N., Mucke L. Pathogenesis of HIV-1 associated neurodegeneration. Crit. Rev. Neurobiol. 10:1996;57-67.
37. Mizrachi Y., Rodriguez I., Sweetnam P. M., Rubinstein A., Volsky D. J. HIV type 1 infection of human cortical neuronal cells: Enhancement by select neuronal growth factors. AIDS Res. Hum. Retroviruses. 10:1994;1593-1596.
38. Muñoz-Fernández M. A., Fresno M. The role of tumor necrosis factor, interleukin 6, interferon-γ, and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog. Neurobiol. 56:1998;307-340.
39. Muñoz-Fernández M. A., Obregón E., Navarro J., Börner C., Gurbindo M. D., Sampelayo T. H., Fernandez-Cruz E. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection. Pediatr. Res. 40:1996;597-602.
40. Muñoz-Fernández M. A., Navarro J., Garcia A., Punzón C., Fernández-Cruz E., Fresno M. Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-NF-κB activation. J. Allergy Clin. Immunol. 100:1997;838-845.
41. Nathan C., Xie Q.-W. Nitric oxide synthases: Roles, tolls, and controls. Cell. 78:1994;915-918.
42. Nuovo G. J., Gallery F., MacConnell P., Braun A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-α RNA in the central nervous system. Am. J. Pathol. 144:1994;659-666.
43. Obregón E., Börner C., Navarro J., Gurbindo M. D., Férnandez-Cruz E., Muñoz-Fernández M. A. Elevated levels of circulating intercellular adhesion Molecule 1 and tumor necrosis factor α in the serum of children vertically infected with HIV-1. Pediatr. AIDS HIV Infect. 7:1996;413-417.
44. Obregón E., Punzón C., Gonzalez-Nicolás J., Fernández-Cruz E., Fresno M., Muñoz-Fernández M. A. Induction of adhesion/differentiation of human neuroblastoma cells by tumour necrosis factor-alpha requires the expression of an inducible nitric oxide synthase. Eur. J. Neurosci. 9:1997;1184-1193.
45. Ogura T., Esumi H. Nitric oxide synthase expression in human neuroblastoma cell line induced by cytokines. Neuroreport. 7:1996;853-856.
46. Peng H. B., Libby P., Liao J. K. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem. 270:1995;14214-14219.
47. Peunova N., Enikolopov G. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature. 375:1995;68-73.
48. Peunova N., Kuzin B., Roberts I., O'Kane C., Enikolopov G. Nitric oxide, cell multiplication and cell survival. Cold Spring Harbor Symp. Quant. Biol. 56:1996;417-426.
49. Pimentel-Muiños F. X., Muñoz-Fernández M. A., Fresno M. Control of T lymphocyte activation and interleukin 2 receptor expression by endogenously secreted lymphokines. J. Immunol. 152:1994;5714-5722.
50. Power C., McArthur J. C., Johnson R. T., Griffin D. E., Glass J. D., Dewey R., Chesebro B. Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence. Curr. Top. Microbiol. Immunol. 202:1995;89-104.
51. Price R. W. AIDS dementia complex: a complex, slow virus "model" of acquired genetic neurodegenerative disease. Cold Spring Harbor Symp. Quant. Biol. 61:1996;759-770.
52. Saito Y., Sharer L. R., Epstein L. G., Michaels J., Mintz M., Louder M., Golding K., Cvetkovich T. A., Blumberg B. M. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology. 44:1994;474-481.
53. Shaw G., Weber K. Differential expression of neurofilament triplet proteins in brain development. Nature. 298:1982;277-279.
54. Springer T. A. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57:1995;827-872.
55. Stefano M., Monno L., Ramon Fiore J., Angarano G. In vivo evidence of HIV-1 productive infection in cerebrospinal fluid of patients with HIV-1 encephalopathy. AIDS. 11:1997;698-699.
56. Stratowa C., Audette M. Transcriptional regulation of the human intercellular adhesion molecule-1 gene: a short overview. Immunobiology. 193:1995;293-304.
57. Thomas F. P., Chalk C., Lalonde R., Robitaille Y., Jolicoeur P. Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease. J. Virol. 68:1994;7099-7107.
58. Tornatore C., Chandra R., Berger J. R., Major E. O. HIV-infection of subcortical astrocytes in the pediatric central nervous system. Neurology. 44:1994;481-487.
59. Truckenmiller M. E., Kulaga H., Coggiano M., Wyatt R., Snyder S. H., Sweetnam P. Human cortical neuronal cell line: a model for HIV-1 infection in an immature neuronal system. AIDS Res. Hum. Retroviruses. 9:1993;445-453.
60. Vesanen M., Salminen M., Wessman M., Lankinen H., Sistonen P., Vaheri A. Morphological differentiation of human SH-SY5Y neuroblastoma cells inhibits human immunodeficiency virus type 1 infection. J. Gen. Virol. 75:1994;201-206.
61. Vesanen M., Wessman M., Salminen M., Vaheri A. Activation of integrated immunodeficiency virus type 1 in human neuroblastoma by the cytokines tumor necrosis factor alpha and interleukin-6. J. Gen. Virol. 73:1992;173-1760.
62. Voraberger G., Schafer R., Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region: Induction by cytokines and phorbol ester. J. Immunol. 147:1991;2777-2786.
63. Wesselingh S. L., Glass J., McArthur J. C., Griffin J. W., Griffin D. E. Cytokine dysregulation in HIV-associated neurological disease. Adv. Neuroimmunol. 4:1994;199-206.